1-112918054-CAATAAATAAATAAATAAATAAATA-CAATAAATA
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_003051.4(SLC16A1):c.362-26_362-11del variant causes a splice polypyrimidine tract, intron change. The variant allele was found at a frequency of 0.0139 in 859,730 control chromosomes in the GnomAD database, including 831 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.014 ( 32 hom., cov: 0)
Exomes 𝑓: 0.014 ( 799 hom. )
Consequence
SLC16A1
NM_003051.4 splice_polypyrimidine_tract, intron
NM_003051.4 splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.97
Genes affected
SLC16A1 (HGNC:10922): (solute carrier family 16 member 1) The protein encoded by this gene is a proton-linked monocarboxylate transporter that catalyzes the movement of many monocarboxylates, such as lactate and pyruvate, across the plasma membrane. Mutations in this gene are associated with erythrocyte lactate transporter defect. Alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 1-112918054-CAATAAATAAATAAATA-C is Benign according to our data. Variant chr1-112918054-CAATAAATAAATAAATA-C is described in ClinVar as [Likely_benign]. Clinvar id is 1570647.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0529 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC16A1 | NM_003051.4 | c.362-26_362-11del | splice_polypyrimidine_tract_variant, intron_variant | ENST00000369626.8 | NP_003042.3 | |||
SLC16A1 | NM_001166496.2 | c.362-26_362-11del | splice_polypyrimidine_tract_variant, intron_variant | NP_001159968.1 | ||||
SLC16A1 | XM_047428789.1 | c.362-26_362-11del | splice_polypyrimidine_tract_variant, intron_variant | XP_047284745.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC16A1 | ENST00000369626.8 | c.362-26_362-11del | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_003051.4 | ENSP00000358640 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0136 AC: 1963AN: 144554Hom.: 30 Cov.: 0
GnomAD3 genomes
AF:
AC:
1963
AN:
144554
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0162 AC: 985AN: 60732Hom.: 202 AF XY: 0.0172 AC XY: 612AN XY: 35678
GnomAD3 exomes
AF:
AC:
985
AN:
60732
Hom.:
AF XY:
AC XY:
612
AN XY:
35678
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0139 AC: 9965AN: 715104Hom.: 799 AF XY: 0.0148 AC XY: 5341AN XY: 361992
GnomAD4 exome
AF:
AC:
9965
AN:
715104
Hom.:
AF XY:
AC XY:
5341
AN XY:
361992
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0136 AC: 1966AN: 144626Hom.: 32 Cov.: 0 AF XY: 0.0147 AC XY: 1034AN XY: 70212
GnomAD4 genome
AF:
AC:
1966
AN:
144626
Hom.:
Cov.:
0
AF XY:
AC XY:
1034
AN XY:
70212
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Metabolic myopathy due to lactate transporter defect;C1864902:Exercise-induced hyperinsulinism;C4015186:Ketoacidosis due to monocarboxylate transporter-1 deficiency Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jan 21, 2022 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at